HealthcareServices

Prenatal Testing & Newborn Screening Industry Growth Insights: Revenue Forecast to 2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal testing & newborn screening market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Prenatal Testing & Newborn Screening Market covering 2026–2035?

The prenatal testing & newborn screening market size has seen substantial growth recently. It is anticipated to expand from $6.98 billion in 2025 to $7.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical growth can be linked to the broadening of public health screening initiatives, an increase in institutional births, the presence of neonatal care facilities, a heightened focus on early disease detection, and improvements in diagnostic testing coverage.

The prenatal testing & newborn screening market is anticipated to experience substantial growth over the coming years, with its size projected to reach $12.22 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by several factors, including the increasing reach of national screening mandates, the rising incorporation of digital diagnostic platforms, augmented investments in maternal and child healthcare, a heightened emphasis on preventive healthcare models, and the expanding utilization of AI-assisted diagnostics. Significant trends anticipated for this period involve the increasing integration of prenatal and newborn screening programs, a growing use of combined screening and diagnostic technologies, the wider implementation of early intervention protocols, the expansion of automated screening workflows, and an intensified focus on population-wide screening efforts.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Prenatal Testing & Newborn Screening Market?

The high incidence of genetic conditions in infants has been a contributing factor to the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic diseases, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, a genetic disorder, impacts millions globally and is particularly common among individuals whose ancestors originate from Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, in February 2023, a study conducted at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine reported that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This significant prevalence of genetic diseases in infants has boosted the demand for the growth of the prenatal testing and newborn screening market. Prenatal Testing & Newborn Screening Market Driver: Rising Birth Rate Fuels Growth Of Prenatal Testing And Newborn Screening Market

What Segments Are Identified Within The Structure Of The Prenatal Testing & Newborn Screening Market?

The prenatal testing & newborn screening market covered in this report is segmented –

1) By Diagnostic Type: Non-Invasive, Invasive

2) By Technology: Screening Technology, Diagnostic Technology

3) By End User: Hospitals, Diagnostic centers

Subsegments:

1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

Which Trends Are Expected To Influence The Prenatal Testing & Newborn Screening Market In The Upcoming Years?

Leading companies within the prenatal testing & newborn screening market are prioritizing the development of newborn screening devices to improve the early identification of genetic, metabolic, and other health conditions. This focus enables prompt interventions and enhances health outcomes for newborns. Newborn screening point-of-care devices are specifically designed to offer quicker, more accessible, and economical screening for infants, capable of performing the seven globally recognized standard newborn screening tests. As an illustration, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian company, introduced MyNeoShield, a new newborn screening point-of-care device. MyNeoShield is intended to be cost-effective, with an estimated price of about one-fifth of existing solutions, which typically cost between ?50 lakhs and ?7 crores. By making testing directly available to healthcare providers, MyNeoShield seeks to expand access to crucial health services for newborns, especially in areas with limited resources.

Which Key Market Players Are Investing In Expansion And Innovation Within The Prenatal Testing & Newborn Screening Market?

Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Which Regions Are Poised For Strategic Growth In The Prenatal Testing & Newborn Screening Market?

North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Prenatal Testing & Newborn Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

Pediatric And Neonatal Testing Kit Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

Prenatal And Newborn Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Non Invasive Prenatal Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795